CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 5 | 2011 | 602 | 672 | 89.6% | |
| CKD 5 | 2012 | 645 | 722 | 89.3% | |
| CKD 5 | 2013 | 628 | 698 | 90.0% | |
| CKD003 | 2014 | 596 | 646 | 92.3% | |
| CKD003 | 2015 | 577 | 619 | 93.2% | |
| NM84 | 2016 | 268 | 338 | 79.3% | |
| NM84 | 2017 | 227 | 291 | 78.0% | |
| NM84 | 2018 | 347 | 476 | 72.9% | |
| NM84 | 2019 | 257 | 363 | 70.8% |
